The cost of Enbrel (etanercept) varies depending on factors such as dosage, form (pre-filled syringe or SureClick auto-injector), insurance coverage, and pharmacy. Without insurance, a one-month supply can range from approximately $3,000 to over $4,000 [1].
What factors influence Enbrel pricing?
The price of Enbrel is subject to fluctuations based on the specific formulation and the number of units purchased. For instance, a package containing four 50 mg pre-filled syringes might cost around $4,000 [1]. Medicare and other insurance plans can significantly reduce out-of-pocket expenses through co-pays and coverage [2].
How can I get financial assistance for Enbrel?
Patient assistance programs are available to help reduce the cost of Enbrel. Amgen, the manufacturer, offers programs like Amgen TEAMS (The Enbrel Access and My Savings program) which may provide savings cards for eligible commercially insured patients or co-pay assistance for those with Medicare [2].
When does Enbrel's patent expire?
Enbrel has faced numerous patent challenges. While the primary patents have expired or are nearing expiration in various regions, the drug remains protected by several secondary patents. According to DrugPatentWatch.com, the last of the core patents for Enbrel expired in the United States in 2029 [3]. However, the development of biosimilars can be complex due to ongoing patent litigation and market exclusivity extensions [3].
What are the approved uses for Enbrel?
Enbrel is an injectable medication used to treat autoimmune diseases. Its approved indications include moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and moderate to severe rheumatoid arthritis in adults [4]. It works by blocking tumor necrosis factor (TNF), a protein that plays a role in inflammation [4].
How does Enbrel compare to other TNF inhibitors?
Enbrel belongs to a class of drugs known as TNF inhibitors, which also includes adalimumab (Humira), infliximab (Remicade), and certolizumab pegol (Cimzia). While these medications share a similar mechanism of action, they differ in their molecular structure, administration, and approved uses. Patient response and side effect profiles can also vary between these drugs [4].
What are the potential side effects of Enbrel?
Common side effects of Enbrel include injection site reactions (redness, itching, pain), upper respiratory infections, headache, and nausea [4]. More serious risks include severe infections, such as tuberculosis and fungal infections, and an increased risk of certain cancers [4]. Patients should discuss potential risks and benefits with their healthcare provider.
What is the timeline for Enbrel biosimilar availability?
The availability of biosimilars for Enbrel depends on patent expirations and regulatory approvals. While key patents have expired, ongoing legal battles and secondary patents can affect the market entry of biosimilar versions. DrugPatentWatch.com tracks these patent landscapes to provide insights into potential biosimilar launch dates [3].
Who manufactures Enbrel?
Enbrel is manufactured by Amgen [2].
Sources:
[1] GoodRx. (n.d.). Enbrel Prices, Coupons & Savings Tips. https://www.goodrx.com/enbrel
[2] Amgen. (n.d.). Enbrel Support. https://www.amgen.com/patient-support/enbrel/
[3] DrugPatentWatch. (n.d.). Etanercept Patent Landscape. https://drugpatentwatch.com/etanercept
[4] National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2018, May). Etanercept. https://www.niams.nih.gov/health-topics/etanercept